Topical Compounded Pain Creams And Pain Perception (TOPCAPP)

Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)

NCT02878798 ·Status: COMPLETED ·Phase: PHASE2

Thermosensitivity of a Topical Palmitated Formulation of Capsaicin

NCT05649228 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

NCT06071949 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06072560 ·Status: UNKNOWN ·Phase: PHASE3

Neurotropin to Treat Chronic Neuropathic Pain

NCT00006289 ·Status: TERMINATED ·Phase: PHASE2

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06071962 ·Status: UNKNOWN ·Phase: PHASE3

Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)

NCT03990649 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071936 ·Status: UNKNOWN ·Phase: PHASE3

Topiramate in the Treatment of Sciatica

NCT00011804 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

NCT00181246 ·Status: COMPLETED ·Phase: NA

Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia

NCT00373893 ·Status: COMPLETED ·Phase: PHASE1

Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)

NCT00916942 ·Status: COMPLETED ·Phase: PHASE2

Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol

NCT03132142 ·Status: UNKNOWN ·Phase: NA

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071988 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of NGX-1998 in Healthy Volunteers

NCT00912262 ·Status: COMPLETED ·Phase: PHASE1

Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects

NCT03997734 ·Status: COMPLETED ·Phase: PHASE1

Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

The Role of TRP Channels in CIPN

NCT04415892 ·Status: RECRUITING ·Phase: NA

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment

NCT03348735 ·Status: TERMINATED ·Phase: PHASE4

Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury

NCT01112748 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

NCT06072573 ·Status: UNKNOWN ·Phase: PHASE3

To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

NCT07060976 ·Status: COMPLETED ·Phase: NA

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

NCT01415895 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain

NCT00414349 ·Status: COMPLETED ·Phase: PHASE3

Effect of Milnacipran in Chronic Neuropathic Low Back Pain

NCT01225068 ·Status: COMPLETED ·Phase: PHASE2